Mobia Medical Inc Dossier
Qualitative Analysis
Business overview
Mobia Medical Inc. (formerly known as MicroTransponder, Inc.) is a commercial-stage medical device company focused on redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets, and sells implantable neurostimulation devices designed to support motor function rehabilitation. Its flagship product is the Vivistim Paired Vagus Nerve Stimulation (VNS) System, which is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System combines targeted vagus nerve stimulation with functional rehabilitation exercises to promote neuroplasticity and drive meaningful improvements in hand and arm movement.
Research as of 29 Mar 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Partnering with U.S. stroke hospitals to establish Vivistim as a standard of care for stroke recovery. The company is targeting the approximately 1,500 stroke hospitals across the United States to shift their focus from acute survival to active stroke recovery.
Expected impact: Aims to drive market awareness, build referral patterns, and expand patient access to Vivistim Therapy across the United States.
Collecting real-world evidence through the GRASP registry to track the durability and usage of Vivistim therapy outside controlled clinical trials. Additionally, the company is studying whether therapist-directed Vivistim therapy can be successfully delivered at home.
Expected impact: Demonstrating long-term real-world efficacy and potentially making the therapy more accessible by allowing home-based treatment.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
MicroTransponder (now Mobia Medical) joined the Innovators' Network at the AHA Center for Health Technology & Innovation to collaborate on digital health technology and raise clinical awareness of stroke recovery solutions.
Terms: Not disclosed